{"id":115750,"date":"2023-06-21T21:14:49","date_gmt":"2023-06-21T21:14:49","guid":{"rendered":"http:\/\/www.brandon.ddtest.info\/multisite-test\/sc-injectable-vyvgart-hytrulo-gets-fda-nod-for-generalized-myasthenia-gravis-monthly-prescribing-reference\/"},"modified":"2023-06-21T21:14:49","modified_gmt":"2023-06-21T21:14:49","slug":"sc-injectable-vyvgart-hytrulo-gets-fda-nod-for-generalized-myasthenia-gravis-monthly-prescribing-reference","status":"publish","type":"post","link":"http:\/\/www.brandon.ddtest.info\/multisite-test\/sc-injectable-vyvgart-hytrulo-gets-fda-nod-for-generalized-myasthenia-gravis-monthly-prescribing-reference\/","title":{"rendered":"SC Injectable Vyvgart Hytrulo Gets FDA Nod for Generalized Myasthenia Gravis – Monthly Prescribing Reference"},"content":{"rendered":"

\n<\/p>\n

    \n
  1. SC Injectable Vyvgart Hytrulo Gets FDA Nod for Generalized Myasthenia Gravis<\/a>  Monthly Prescribing Reference<\/font><\/li>\n
  2. FDA Approves Subcutaneous Efgartigimod as Treatment for Generalized Myasthenia Gravis<\/a>  Neurology Live<\/font><\/li>\n
  3. Halozyme Announces argenx Receives FDA Approval for VYVGART\u00ae Hytrulo With ENHANZE\u00ae for Subcutaneous Use in Generalized Myasthenia Gravis<\/a>  Yahoo Finance<\/font><\/li>\n
  4. argenx Announces U.S. Food and Drug Administration Approval<\/a>  GlobeNewswire<\/font><\/li>\n
  5. Argenx’s Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis<\/a>  Benzinga<\/font><\/li>\n
  6. View Full Coverage on Google News<\/a><\/strong><\/li>\n<\/ol>\n\n
    Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    SC Injectable Vyvgart Hytrulo Gets FDA Nod for Generalized Myasthenia Gravis  Monthly Prescribing Reference FDA Approves Subcutaneous Efgartigimod as Treatment for Generalized Myasthenia Gravis  Neurology Live Halozyme Announces argenx Receives FDA Approval for VYVGART\u00ae Hytrulo With ENHANZE\u00ae for Subcutaneous Use in Generalized Myasthenia Gravis  Yahoo Finance argenx Announces U.S. Food and Drug Administration Approval  GlobeNewswire Argenx’s Vyvgart Hytrulo Becomes …<\/p>\n","protected":false},"author":1,"featured_media":115751,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[161],"tags":[],"_links":{"self":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts\/115750"}],"collection":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/comments?post=115750"}],"version-history":[{"count":0,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts\/115750\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/media\/115751"}],"wp:attachment":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/media?parent=115750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/categories?post=115750"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/tags?post=115750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}